ABCURO
Newton, MA
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartments of the immune system. The company was incorporated in 2015 and is based in Newton, Massachusetts.
abcuro.comEmploybl Premium
Get the inside track on ABCURO
Premium profiles, AI research on tech stack and hiring, 61,000+ ATS job listings, saved searches, and an AI chat that knows the SF startup scene.
- AI chat about ABCURO's culture, stack, and interview process
- Save jobs and get alerts on new openings
- Full premium profiles across our company index
- 7-day free trial, then $25/mo. Cancel anytime.
Company Details
Founded
- 2020
Employees
- Between 10 - 100 employees
Raised
- $414,849,984
Headquarters Location
- Newton, MA
Public
- No
Acquired
- No
CEO
Alex Martin
Founders
- Stefano Gulla
Company Collections
These are collections ABCURO is a part of. Click on the collection name to view similar companies.
ABCURO's Industries
ABCURO Headquarters Location
Total Amount Raised: $414,849,984
ABCURO Funding Rounds
Series C
$200,000,000
Series C
$200,000,000
Series C Investors
NEA - New Enterprise AssociatesPontifaxBain Capital Life Sciences FundSanofi VenturesForesite CapitalSamsara BioCapitalRA Capital ManagementMass General Brigham VenturesNew Leaf VenturesRedmile GroupAbrdnBlackRockSoleus CapitalEurofarma VenturesSeries B
$155,000,000
Series B
$155,000,000
Series B Investors
Bain Capital Life Sciences FundRedmile GroupNew Leaf VenturesSoleus CapitalBlackRockSamsara BioCapitalMass General Brigham VenturesPontifaxRA Capital ManagementSanofi VenturesEurofarma VenturesTekla Capital ManagementSeries A
$42,000,000
Series A
$42,000,000
Series A Investors
Mass General Brigham VenturesSanofi VenturesPontifaxSamsara BioCapitalRA Capital ManagementHongsen Investment GroupSeries Unknown
$7,599,990
Series Unknown
$7,599,990
Series A
$8,000,000
Series A
$8,000,000
Series A Investors
Partners Innovation FundShangPharma InnovationKaitai CapitalSeed
$2,250,000
Seed
$2,250,000
ABCURO Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ABCURO.